Search: onr:"swepub:oai:DiVA.org:uu-446850" > Clinical risk score...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04867naa a2200517 4500 | |
001 | oai:DiVA.org:uu-446850 | |
003 | SwePub | |
008 | 210805s2021 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4468502 URI |
024 | 7 | a https://doi.org/10.1093/ehjacc/zuaa0162 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Steiro, Ole-Thomasu Haukeland Hosp, Dept Heart Dis, Bergen, Norway.4 aut |
245 | 1 0 | a Clinical risk scores identify more patients at risk for cardiovascular events within 30 days as compared to standard ACS risk criteria :b the WESTCOR study |
264 | c 2020-10-02 | |
264 | 1 | b Oxford University Press,c 2021 |
338 | a electronic2 rdacarrier | |
520 | a Aims Troponin-based algorithms are made to identify myocardial infarctions (MIs) but adding either standard acute coronary syndrome (ACS) risk criteria or a clinical risk score may identify more patients eligible for early discharge and patients in need of urgent revascularization. Methods and results Post-hoc analysis of the WESTCOR study including 932 patients (mean 63years, 61% male) with suspected NSTE-ACS. Serum samples were collected at 0, 3, and 8-12h and high-sensitivity cTnT (Roche Diagnostics) and cTnI (Abbott Diagnostics) were analysed. The primary endpoint was MI, all-cause mortality, and unplanned revascularizations within 30days. Secondary endpoint was non-ST-elevation myocardial infarction (NSTEMI) during index hospitalization. Two combinations were compared: troponin-based algorithms (ESC 0/3h and the High-STEACS algorithm) and either ACS risk criteria recommended in the ESC guidelines, or one of eleven clinical risk scores, HEART, mHEART, CARE, GRACE, T-MACS, sT-MACS, TIMI, EDACS, sEDACS, Goldman, and Geleijnse-Sanchis. The prevalence of primary events was 21%. Patients ruled out for NSTEMI and regarded low risk of ACS according to ESC guidelines had 3.8-4.9% risk of an event, primarily unplanned revascularizations. Using HEART score instead of ACS risk criteria reduced the number of events to 2.2-2.7%, with maintained efficacy. The secondary endpoint was met by 13%. The troponin-based algorithms without evaluation of ACS risk missed three-index NSTEMIs with a negative predictive value (NPV) of 99.5% and 99.6%. Conclusion Combining ESC 0/3h or the High-STEACS algorithm with standardized clinical risk scores instead of ACS risk criteria halved the prevalence of rule-out patients in need of revascularization, with maintained efficacy. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng |
653 | a Chest pain | |
653 | a High-sensitivity troponin assay | |
653 | a ESC 0/3h algorithm | |
653 | a High-STEACS | |
653 | a Risk score | |
653 | a Revascularization | |
700 | 1 | a Tjora, Hilde L.u Haukeland Hosp, Emergency Care Clin, Bergen, Norway.4 aut |
700 | 1 | a Langorgen, Jorundu Haukeland Hosp, Dept Heart Dis, Bergen, Norway.4 aut |
700 | 1 | a Bjorneklett, Runeu Haukeland Hosp, Emergency Care Clin, Bergen, Norway.;Univ Bergen, Dept Clin Med, Bergen, Norway.4 aut |
700 | 1 | a Nygård, Ottar K.u Haukeland Hosp, Dept Heart Dis, Bergen, Norway.;Univ Bergen, Dept Clin Med, Bergen, Norway.4 aut |
700 | 1 | a Skadberg, Oyvindu Stavanger Univ Hosp, Lab Med Biochem, Stavanger, Norway.4 aut |
700 | 1 | a Bonarjee, Vernon V. S.u Stavanger Univ Hosp, Dept Cardiol, Stavanger, Norway.4 aut |
700 | 1 | a Lindahl, Bertil,d 1957-u Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Kardiologi4 aut0 (Swepub:uu)belin227 |
700 | 1 | a Omland, Torbjornu Akershus Univ Hosp, Div Med, Oslo, Norway.;Univ Oslo, Fac Med, Ctr Heart Failure Res, Inst Clin Med, Oslo, Norway.4 aut |
700 | 1 | a Vikenes, Kjellu Haukeland Hosp, Dept Heart Dis, Bergen, Norway.;Univ Bergen, Dept Clin Med, Bergen, Norway.4 aut |
700 | 1 | a Aakre, Kristin M.u Univ Bergen, Dept Clin Med, Bergen, Norway.;Haukeland Hosp, Dept Med Biochem & Pharmacol, Jonas Lies Vei 65, N-5021 Bergen, Norway.4 aut |
710 | 2 | a Haukeland Hosp, Dept Heart Dis, Bergen, Norway.b Haukeland Hosp, Emergency Care Clin, Bergen, Norway.4 org |
773 | 0 | t European Heart Journald : Oxford University Pressg 10:3, s. 287-301q 10:3<287-301x 2048-8726x 2048-8734 |
856 | 4 | u https://doi.org/10.1093/ehjacc/zuaa016y Fulltext |
856 | 4 | u https://uu.diva-portal.org/smash/get/diva2:1583280/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u https://doi.org/10.1093/ehjacc/zuaa016 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-446850 |
856 | 4 8 | u https://doi.org/10.1093/ehjacc/zuaa016 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.